Co-Activation of STAT3 and YAP1 Signaling Pathways Limits EGFR Inhibitor Response in Lung Cancer

被引：0

作者：

Karachaliou, Niki ^{[1
]}

Chaib, Imane ^{[2
]}

Cardona, Andres ^{[3
]}

Lopez-Vivanco, Guillermo ^{[4
]}

Vergnenegre, Alain ^{[5
]}

Miguel Sanchez, Jose ^{[6
]}

Provencio, Mariano ^{[7
]}

De Marinis, Filippo ^{[8
]}

Passaro, Antonio ^{[8
]}

Carcereny, Enric ^{[9
]}

Reguart, Noemi ^{[10
]}

Garcia Campelo, Rosario ^{[11
]}

Santarpia, Mariacarmela ^{[12
]}

Viteri, Santiago ^{[1
]}

Molina Vila, Miguel Angel ^{[13
]}

Li, Xuefei ^{[14
]}

Zhou, Caicun ^{[15
]}

Moran, Teresa ^{[9
]}

Ramirez Serrano, Jose Luis ^{[2
,16
]}

Bivona, Trever ^{[17
]}

Ma, Patrick ^{[18
]}

Drozdowskyj, Ana ^{[19
]}

Cao, Peng ^{[20
]}

Rosell, Rafael ^{[21
]}

机构：

[1] Hosp Univ Quiron Dexeus, IOR, Barcelona, Spain

[2] Inst Invest Ciencies Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain

[3] Clin Country, Clin & Translat Oncol Grp, Bogota, Colombia

[4] Hosp Cruces, Baracaldo, Spain

[5] CHU Limoges, Limoges, France

[6] Hosp Univ La Princesa, Madrid, Spain

[7] Hosp Univ Puerta Hierro, Madrid, Spain

[8] European Inst Oncol, Div Thorac Oncol, Milan, Italy

[9] Catalan Inst Oncol Hospital Germans Trios & Pujol, Med Oncol, Badalona, Spain

[10] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[11] Hosp Univ A Coruna, La Coruna, Spain

[12] Univ Messina, Oncol & Pathol, Messina, Italy

[13] Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

[14] Shanghai Pulm Hosp, Med Oncol, Shanghai, Peoples R China

[15] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China

[16] Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

[17] UCSF, Med, San Francisco, CA USA

[18] Wvu Canc Inst, Morgantown, WV USA

[19] Pivotal Sl, Stat, Madrid, Spain

[20] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China

[21] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

lung cancer; STAT3; signaling; EGFR Inhibitor; YAP1;

D O I：

10.1016/j.jtho.2016.11.1714

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02b-047

引用

页码：S1216 / S1217

页数：2

共 50 条

[1] Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Chaib, Imane
Karachaliou, Niki
Pilotto, Sara
Codony Servat, Jordi
Cai, Xueting
Li, Xuefei
Drozdowskyj, Ana
Codony Servat, Carles
Yang, Jie
Hu, Chunping
Felipe Cardona, Andres
Vivanco, Guillermo Lopez
Vergnenegre, Alain
Miguel Sanchez, Jose
Provencio, Mariano
de Marinis, Filippo
Passaro, Antonio
Carcereny, Enric
Reguart, Noemi
Garcia Campelo, Charo
Teixido, Cristina
Sperduti, Isabella
Rodriguez, Sonia
Lazzari, Chiara
Verlicchi, Alberto
de Aguirre, Itziar
Queralt, Cristina
Wei, Jia
Estrada, Roger
Puig de la Bellacasa, Raimon
Luis Ramirez, Jose
Jacobsen, Kirstine
Ditzel, Henrik J.
Santarpia, Mariacarmela
Viteri, Santiago
Angel Molina, Miguel
Zhou, Caicun
Cao, Peng
Ma, Patrick C.
Bivona, Trever G.
Rosell, Rafael
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (09):
[2] YAP-NOTCH and STAT3 Signaling Rebound as a Compensatory Response to Gefitinib or Osimertinib Treatment in EGFR Mutant Lung Cancer
Rosell, Rafael
Chaib, Imane
Karachaliou, Niki
Cao, Peng
Molina Vila, Miguel Angel
Cai, Xueting
Drozdowskyj, Ana
Yang, Jie
Hu, Chunping
Cardona, Andres
Frias, Alex
Lazzari, Chiara
Verlicchi, Alberto
Codony Servat, Jordi
Codony Servat, Carles
Ramirez Serrano, Jose Luis
Vergnenegre, Alain
Ma, Patrick
Bivona, Trever
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S281 - S282
[3] Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells
Akca, Hakan
Tani, Masachika
Hishida, Tomoyuki
Matsumoto, Shingo
Yokota, Jun
LUNG CANCER, 2006, 54 (01) : 25 - 33
[4] The Prognostic Impact of SIRT1, STAT3, and YAP1 in Colorectal Carcinoma
Elkholy, Shimaa
Abdelbary, Aya
Elazab, Dina
Elkablawy, Mohamed
Abdou, Asmaa G.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2025, 33 (01) : 29 - 42
[5] 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling
Liu, Ren
Choi, Hack Sun
Ko, Yu-Chan
Yun, Bong-Sik
Lee, Dong-Sun
LIFE SCIENCES, 2021, 280
[6] Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
Sen, Malabika
Joyce, Sonali
Panahandeh, Mary
Li, Changyou
Thomas, Sufi M.
Maxwell, Jessica
Wang, Lin
Gooding, William E.
Johnson, Daniel E.
Grandis, Jennifer R.
CLINICAL CANCER RESEARCH, 2012, 18 (18) : 4986 - 4996
[7] STAT3 signaling mediates FAK inhibitor response and resistance in pancreatic cancer
Jiang, Hong
Knolhoff, Brett L.
Krisnawan, Varintra
DeNardo, David
FASEB JOURNAL, 2018, 32 (01):
[8] Co-activation of myeloid signaling pathways for pancreatic cancer immunotherapy.
Wattenberg, Max M.
Coho, Heather
Herrera, Veronica M.
Graham, Kathleen
Stone, Meredith L.
Xue, Yuqing
Chang, Renee B.
Cassella, Christopher
Liu, Mingen
Choi-Bose, Shaanti
Thomas, Stacy K.
Choi, Hana
Li, Yan
Melendez, Lauren
Giannone, Michael
Bose, Nandita
Beatty, Gregory L.
CANCER RESEARCH, 2022, 82 (22) : 123 - 124
[9] Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3
Thilakasiri, Pathum
O'Keefe, Ryan N.
To, Sarah Q.
Chisanga, David
Eissmann, Moritz F.
Carli, Annalisa L. E.
Duscio, Belinda
Baloyan, David
Dmello, Rhynelle S.
Williams, David
Mariadason, John
Poh, Ashleigh R.
Pal, Bhupinder
Kile, Benjamin
Vissers, Joseph H. A.
Harvey, Kieran F.
Buchert, Michael
Shi, Wei
Ernst, Matthias
Chand, Ashwini L.
LIFE SCIENCE ALLIANCE, 2023, 7 (02)
[10] YAP1 induces STAT3 phosphorylation & combined blockade enhances chemotherapeutic efficacy
Shibata, Masahiro
Ooki, Akira
Inokawa, Yoshikuni
Izumchenko, Evgeny
Munari, Enrico
Bogina, Giuseppe
Gabrielson, Edward
Singh, Anju
Hoque, Mohammad Obaidul
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →